Goldman Sachs
ELAN icon

Goldman Sachs’s Elanco Animal Health ELAN Stock Holding History

Goldman Sachs’s Portfolio ELAN Stock Details ELAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-197,900
Closed -$2.46M – 6049
2022
Q3 		$2.46M Buy
+197,900
New +$3.46M ﹤0.01% 3806
2019
Q4 		– Sell
-97,900
Closed -$2.6M – 5258
2019
Q3 		$2.6M Buy
+97,900
New +$2.94M ﹤0.01% 3358

Other funds holding ELAN

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

Goldman Sachs's ELAN Position: Q1 2026 in Review

Goldman Sachs reduced its Elanco Animal Health (ELAN) stake by 3.6% in Q1 2026, selling an estimated $1.31M and leaving 1,434,135 shares worth $34.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1909.

Goldman Sachs first reported a position in ELAN in Q3 2018 and has held it in 31 quarters since. The position peaked at $345M in Q2 2021. 515 funds tracked by Wall St. Rank hold ELAN as of Q1 2026.

  • Goldman Sachs held 1,434,135 shares of Elanco Animal Health worth $34.3M as of Q1 2026.
  • Goldman Sachs sold 53,574 Elanco Animal Health shares in Q1 2026, an estimated $1.31M.
  • Elanco Animal Health made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #1909 holding.
  • Goldman Sachs first reported a position in Elanco Animal Health in Q3 2018 and has held it in 31 quarters since.
  • Goldman Sachs's Elanco Animal Health position peaked at $345M in Q2 2021.
  • 515 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.